Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT

Cardiovascular Research

Volumn 83, Issue 4, 2009, Pages 778-784

  Rosenkranz, Anke C ^a   Rauch, Bernhard H ^a   Freidel, Kerstin ^a   Schrör, Karsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cyclosporine; Nuclear factor of activated T cells; Prostaglandins; Thrombin receptors; Vascular smooth muscle

Indexed keywords

BUTAPROST; CYCLOOXYGENASE 2; CYCLOSPORIN A; ILOPROST; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEINASE ACTIVATED RECEPTOR 1; SMALL INTERFERING RNA; THROMBIN; TRANSCRIPTION FACTOR NFAT;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE;

BASE SEQUENCE; CELLS, CULTURED; CYCLOSPORINE; DNA; HUMANS; ILOPROST; INTERLEUKIN-6; MODELS, BIOLOGICAL; MYOCYTES, SMOOTH MUSCLE; NFATC TRANSCRIPTION FACTORS; OLIGOPEPTIDES; PROMOTER REGIONS, GENETIC; PROSTAGLANDINS; RECEPTOR, PAR-1; RNA, MESSENGER; RNA, SMALL INTERFERING; TETRADECANOYLPHORBOL ACETATE; THROMBIN; TRANSCRIPTION, GENETIC; VASODILATION;

EID: 68949100635     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp163     Document Type: Article

References (37)

1. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258-264.
2. Bretschneider E, Kaufmann R, Braun M, Nowak G, Glusa E, Schrör K. Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells. Br J Pharmacol 2001;132: 1441-1446.
3. Bretschneider E, Spanbroek R, Lotzer K, Habenicht AJ, Schrör K. Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells. Thromb Haemost 2003;90:704-709.
4. Andrade-Gordon P, Derian CK, Maryanoff BE, Zhang HC, Addo MF, Cheung W et al. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J Pharmacol Exp Ther 2001;298: 34-42.
5. Patterson C, Stouffer GA, Madamanchi N, Runge MS. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology. Circ Res 2001;88:987-997.
6. O'Brien PJ, Molino M, Kahn M, Brass LF. Protease activated receptors: theme and variations. Oncogene 2001;20:1570-1581.
7. Pape R, Rauch BH, Rosenkranz AC, Kaber G, Schrör K. Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2008;28:534-540.
8. Subramanian VA, Hernandez Y, Tack-Goldman K, Grabowski EF, Weksler BB. Prostacyclin production by internal mammary artery as a factor in coronary artery bypass grafts. Surgery 1986;100:376-383.
9. Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene 2001;20:2476-2489.
10. Sheridan CM, Heist EK, Beals CR, Crabtree GR, Gardner P. Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3. J Biol Chem 2002;277:48664-48676.
11. Li W, Handschumacher RE. Regulation of the nuclear factor of activated T cells in stably transfected Jurkat cell clones. Biochem Biophys Res Commun 1996;219:96-99.
12. Wada H, Hasegawa K, Morimoto T, Kakita T, Yanazume T, Abe M et al. Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription. J Cell Biol 2002;156:983-991.
13. Yellaturu CR, Ghosh SK, Rao RK, Jennings LK, Hassid A, Rao GN. A potential role for nuclear factor of activated T-cells in receptor tyrosine kinase and G-protein-coupled receptor agonist-induced cell proliferation. Biochem J 2002;368:183-190.
14. Yu H, Sliedregt-Bol K, Overkleeft H, van der Marel GA, van Berkel TJ, Biessen EA. Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent. Arterioscler Thromb Vasc Biol 2006;26:1531-1537.
15. Liu Z, Zhang C, Dronadula N, Li Q, Rao GN. Blockade of nuclear factor of activated T cells activation signaling suppresses balloon injury-induced neointima formation in a rat carotid artery model. J Biol Chem 2005; 280:14700-14708.
16. Fallier-Becker P, Rupp J, Fingerle J, Betz E. Smooth muscle cells from rabbit aorta. In: Piper H, ed. Cell Culture Techniques in Heart and Vessel Research. Berlin/Heidelberg/New York: Springer Verlag; 1990. 247-270.
17. Braun M, Pietsch P, Zepp A, Schrör K, Baumann G, Felix SB. Regulation of tumor necrosis factor alpha- and interleukin-1-beta-induced induced adhesion molecule expression in human vascular smooth muscle cells by cAMP. Arterioscler Thromb Vasc Biol 1997;17:2568-2575.
18. Rauch BH, Bretschneider E, Braun M, Schrör K. Factor Xa releases matrix metalloproteinase-2 (MMP-2) from human vascular smooth muscle cells and stimulates the conversion of pro-MMP-2 to MMP-2: role of MMP-2 in factor Xa-induced DNA synthesis and matrix invasion. Circ Res 2002;90: 1122-1127.
19. Rauch BH, Weber A, Braun M, Zimmermann N, Schrör K. PDGF-induced Akt phosphorylation does not activate NF-kappa B in human vascular smooth muscle cells and fibroblasts. FEBS Lett 2000;481:3-7.
20. Aparicio O, Geisberg JV, Sekinger E, Yang A, Moqtaderi Z, Struhl K. Chromatin immunoprecipitation for determining the association of proteins with specific genomic sequences in vivo. In: Ausubel FM et al., ed. Current Protocols in Molecular Biology. Hoboken, New Jersey, USA: John Wiley & Sons, Ltd. 2005. Chapter 21:Unit 21-23.
21. Debey S, Meyer-Kirchrath J, Schrör K. Regulation of cyclooxygenase-2 expression by iloprost in human vascular smooth muscle cells. Role of transcription factors CREB and ICER. Biochem Pharmacol 2003;65: 979-988.
22. Rabausch K, Bretschneider E, Sarbia M, Meyer-Kirchrath J, Censarek P, Pape R et al. Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins. Circ Res 2005;96: e1-e6.
23. Nilsson J, Nilsson LM, Chen YW, Molkentin JD, Erlinge D, Gomez MF. High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler Thromb Vasc Biol 2006;26:794-800.
24. Liu Z, Dronadula N, Rao GN. A novel role for nuclear factor of activated T cells in receptor tyrosine kinase and G protein-coupled receptor agonist-induced vascular smooth muscle cell motility. J Biol Chem 2004;279:41218-41226.
25. Tokunou T, Ichiki T, Takeda K, Funakoshi Y, Iino N, Shimokawa H et al. Thrombin induces interleukin-6 expression through the cAMP response element in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001;21:1759-1763.
26. Marmur JD, Merlini PA, Sharma SK, Khaghan N, Torre SR, Israel DH et al. Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. J Am Coll Cardiol 1994;24:1484- 1491.
27. Belton O, Byrne D, Kearney D, Leahy A, Fitzgerald DJ. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 2000;102:840-845.
28. Sokolova E, Hartig R, Reiser G. Downregulation of protease-activated receptor-1 in human lung fibroblasts is specifically mediated by the prostaglandin E receptor EP2 through cAMP elevation and protein kinase A. FEBS J 2008;275:3669-3679.
29. Hao S, Kurosaki T, August A. Differential regulation of NFATand SRF by the B cell receptor via a PLCgamma-Ca(2+)-dependent pathway. EMBO J 2003;22:4166-4177.
30. Ikeda U, Ikeda M, Seino Y, Takahashi M, Kano S, Shimada K. Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits. Atherosclerosis 1992;92:213-218.
31. Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa Tet al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994;6:87-91.
32. Nakano K, Egashira K, Tada H, Kohjimoto Y, Hirouchi Y, Kitajima S et al. A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in nonhuman primates. J Hypertens 2006;24:1881-1889.
33. Beals CR, Clipstone NA, Ho SN, Crabtree GR. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev 1997;11:824-834.
34. Okamura H, Aramburu J, Garcia-Rodriguez C, Viola JP, Raghavan A, Tahiliani M et al. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell 2000;6:539-550.
35. Schermuly RT, Pullamsetti SS, Breitenbach SC, Weissmann N, Ghofrani HA, Grimminger F et al. Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs. Respir Res 2007;8:4.
36. Smyth EM, Li WH, FitzGerald GA. Phosphorylation of the prostacyclin receptor during homologous desensitization. A critical role for protein kinase c. J Biol Chem 1998;273:23258-23266.
37. Kasza Z, Fetalvero KM, Ding M, Wagner RJ, Acs K, Guzman AK et al. Novel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation. J Mol Cell Cardiol 2009;46: 682-694.